ZMB Member Adalbert Krawczyk

ZMB Member
Adalbert Krawczyk

Next ZMB-Member
Adalbert Krawczyk
© UKE/Krawczyk

Prof. Dr. Adalbert Krawczyk

Clinic for Infectious Diseases

University Hospital Essen
Hufelandstr. 55
45147 Essen

Research Overview

  • Anti-HSV antibodies
  • Nanoparticle based vaccines
  • Anti-CMV antibodies
  • Coronavirus SARS-CoV-2
  • Antiviral Natural Products and Herbal Medicines
  • Modification of exosomes for the development of new vaccines
Read more

Selected Publications

    Journal articles

  • Wu, Jun; Liang, Boyun; Chen, Cunrong; Wang, Hua; Fang, Yaohui; Shen, Shu; Yang, Xiaoli; Wang, Baoju; Chen, Liangkai; Chen, Qi; Wu, Yang; Liu, Jia; Yang, Xuecheng; Li, Wei; Zhu, Bin; Zhou, Wenqing; Wang, Huan; Li, Sumeng; Lu, Sihong; Liu, Di; Li, Huadong; Krawczyk, Adalbert; Lu, Mengji; Yang, Dongliang; Deng, Fei; Dittmer, Ulf; Trilling, Mirko; Zheng, Xin
    SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
    In: Nature Communications , Vol. 12 2021, Nr. 1, pp. 1813
    DOI (Open Access)
  • Lang, Judith; Bohn, Patrick; Bhat, Hilal; Jastrow, Holger; Walkenfort, Bernd; Cansiz, Feyza; Fink, Julian; Bauer, Michael; Olszewski, Dominik; Ramos-Nascimento, Ana; Duhan, Vikas; Friedrich, Sarah-Kim; Becker-Flegler, Katrin; Krawczyk, Adalbert; Edwards, Michael J.; Burchert, Andreas; Huber, Magdalena; Friebus-Kardash, Justa; Göthert, Joachim Rudolf; Hardt, Cornelia; Probst, Hans Christian; Schumacher, Fabian; Köhrer, Karl; Kleuser, Burkhard; Babiychuk, Eduard B.; Sodeik, Beate; Seibel, Jürgen; Greber, Urs F.; Lang, Philipp A.; Gulbins, Erich; Lang, Karl S.
    Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
    In: Nature Communications , Vol. 11 2020, Nr. 1, pp. 1338
    DOI, Online Full Text (Open Access)
  • Bazinet, Michel; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatiana; Jucov, Alina; Dittmer, Ulf; Krawczyk, Adalbert; Vaillant, Andrew
    Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
    In: Gastroenterology , Vol. 158 2020, Nr. 8, pp. 2180 – 2194
    DOI (Open Access)
  • Karimzadeh, Hadi; Kiraithe, Muthamia M.; Oberhardt, Valerie; Salimi Alizei, Elahe; Bockmann, Jan; Schulze zur Wiesch, Julian; Budeus, Bettina; Hoffmann, Daniel; Wedemeyer, Heiner; Cornberg, Markus; Krawczyk, Adalbert; Rashidi-Alavijeh, Jassin; Rodríguez-Frías, Francisco; Casillas, Rosario; Buti, Maria; Smedile, Antonina; Alavian, Seyed Moayed; Heinold, Andreas; Emmerich, Florian; Panning, Marcus; Gostick, Emma; Price, David A.; Timm, Jörg; Hofmann, Maike; Raziorrouh, Bijan; Thimme, Robert; Protzer, Ulrike; Roggendorf, Michael; Neumann-Haefelin, Christoph
    Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8⁺ T Cells and Evolve at the Population Level
    In: Gastroenterology , Vol. 156 2019, Nr. 6, pp. 1820 – 1833
    DOI (Open Access)
  • Krawczyk, Adalbert; Bazinet, Michel; Pantea, Victor; Cotler, Scott; Dahari, Harel; Shekhtman, Louis; Jimbei, Pavlina; Cojuhari, Lilia; Cebotarescu, Valentin; Uprichard, Susan; Vaillant, Andrew
    Understanding HDV and HBsAg kinetics during nucleic acid polymer REP 2139 mono-therapy in HBeAg-negative chronic HBV/HDV co-infected patients via mathematical modeling
    In: Journal of Hepatology , Vol. 70 2019, Nr. 1 Suppl., pp. e463
    DOI
  • Krawczyk, Adalbert; et.al.
    Establishment of High Rates of Functional Control and Reversal of Fibrosis Following Treatment of Hbeag Negative Chronic HBV Infection with REP 2139-Mg / REP 2165-Mg, Tenofovir Disoproxil Fumarate and Pegylated Interferon Alpha-2a
    In: Hepatology , Vol. 68 2018, Nr. S1, pp. 234A – 235A
    DOI
  • Cojuhari, L.; Cebotarescu, V.; Krawczyk, Adalbert; Bazinet, M.; Pantea, V.; Vaillant, A.; Jimbei, P.
    One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial : REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infection
    In: Journal of Hepatology , Vol. 66 2017, Nr. 1, pp. S96 – S97
    DOI
  • Smesnoi, V.; Vaillant, A.; Pantea, V.; Cebotarescu, V.; Iarovoi, L.; Placinta, G.; Moscalu, I.; Krawczyk, Adalbert; Jimbei, P.; Bazinet, M.; Musteata, T.; Jucov, A.; Cojuhari, L.
    Update on safety and efficacy in the REP 401 protocol : REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infection
    In: Journal of Hepatology , Vol. 66 2017, Nr. 1, pp. S256 – S257
    DOI
Read more